Target Corporation
Target Corporation (TGT) Financial Performance & Income Statement Overview
Review Target Corporation (TGT) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Target Corporation (TGT) Income Statement & Financial Overview
View the income breakdown for Target Corporation TGT across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $23.85B | $30.91B | $25.67B | $25.45B |
| Cost of Revenue | $17.78B | $23.45B | $19.01B | $18.43B |
| Gross Profit | $6.06B | $7.47B | $6.65B | $7.03B |
| Gross Profit Ratio | $0.25 | $0.24 | $0.26 | $0.28 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.18B | $5.97B | $5.49B | $5.36B |
| Operating Expenses | $5.18B | $5.97B | $5.49B | $5.36B |
| Total Costs & Expenses | $22.97B | $29.42B | $24.50B | $23.78B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $116.00M | $90.00M | $105.00M | $110.00M |
| Depreciation & Amortization | $787.00M | $766.00M | $754.00M | $743.00M |
| EBITDA | $2.29B | $2.27B | $1.96B | $2.40B |
| EBITDA Ratio | $0.10 | $0.07 | $0.08 | $0.09 |
| Operating Income | $879.00M | $1.50B | $1.17B | $1.67B |
| Operating Income Ratio | $0.04 | $0.05 | $0.05 | $0.07 |
| Other Income/Expenses (Net) | $503.00M | -$92.00M | -$78.00M | -$126.00M |
| Income Before Tax | $1.38B | $1.41B | $1.09B | $1.54B |
| Income Before Tax Ratio | $0.06 | $0.05 | $0.04 | $0.06 |
| Income Tax Expense | $346.00M | $303.00M | $237.00M | $353.00M |
| Net Income | $1.04B | $1.10B | $854.00M | $1.19B |
| Net Income Ratio | $0.04 | $0.04 | $0.03 | $0.05 |
| EPS | $2.28 | $2.42 | $1.86 | $2.58 |
| Diluted EPS | $2.27 | $2.41 | $1.85 | $2.57 |
| Weighted Avg Shares Outstanding | $455.00M | $456.80M | $460.10M | $462.50M |
| Weighted Avg Shares Outstanding (Diluted) | $456.50M | $458.40M | $461.50M | $463.50M |
Over the past four quarters, Target Corporation demonstrated steady revenue growth, increasing from $25.45B in Q2 2024 to $23.85B in Q1 2025. Operating income reached $879.00M in Q1 2025, maintaining a consistent 4% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $2.29B, reflecting operational efficiency. Net income dropped to $1.04B, with EPS at $2.28. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan